Company intelligence / Profile preview

Melax Technologies

Houston, Texas, United Stateshighergov.com ↗

Ownership: Private
Employees: ~21
Development stage: Other

Overview

Melax Technologies developed advanced AI and NLP platforms to extract structured information from unstructured biomedical and clinical text. Their solutions have been used to improve patient care, streamline clinical workflows, enhance research productivity through better metadata management of datasets, support early detection of cognitive decline using EHRs and deep learning, and facilitate cancer clinical trial recruitment via improved informed consent processes. The company was acquired by Intelligent Medical Objects in May 2023 to expand IMO’s healthcare data quality offerings.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

National Institutes of Health/National Institute on Aging/National Cancer Institute/NIAID via SBIR grants

Beyond the preview

Go deeper on Melax Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melax Technologies.

Explore the full profile